Evidence synthesis in harm assessment of medicines using the example of rosiglitazone and myocardial infarction
Charlotte Rietbergen*, Gudrun Stefansdottir, Hubert G. Leufkens, Mirjam J. Knol, Marie L. De Bruin, Irene Klugkist
*Corresponding author for this work
Fingerprint
Dive into the research topics of 'Evidence synthesis in harm assessment of medicines using the example of rosiglitazone and myocardial infarction'. Together they form a unique fingerprint.